CS MEDICA defers the Q4 2022/2023 quarterly report until Wednesday 22. November 2023

CS MEDICA is postponing the Year-end-Report Q4 2022/2023 until Wednesday 22. November 2023.

CS MEDICA A/S ("CS MEDICA" or the "Company"), a MedTech company that focuses on treating pain, autoimmune diseases, and stress-related disorders with therapeutic CBD/cannabinoids, is postponing its quarterly report Q4 2022/2023 to Wednesday, 22 November 2023.